Prober Charles J. 4
4 · Life360, Inc. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Life360 (LIF) Director Charles J. Prober Exercises Options, Sells Shares
What Happened Charles J. Prober, a director of Life360 (LIF), exercised 7,930 stock options on March 13, 2026 at an exercise price of $11.18 per share (cost $88,657) and immediately sold 7,930 shares in an open-market transaction at $41.40 per share (gross proceeds $328,302). The Form 4 also reports a derivative disposition for 7,930 shares at $0, consistent with conversion/exercise of the option. Net of the exercise cost, the transaction produced a gross difference of about $239,645 before taxes and fees. These trades were executed under a pre-established Rule 10b5-1 plan.
Key Details
- Transaction date: March 13, 2026 (filed March 17, 2026; filing appears within the normal Form 4 timeframe)
- Exercise: 7,930 shares at $11.18 — total cost $88,657
- Sale: 7,930 shares at $41.40 — gross proceeds $328,302
- Derivative note: 7,930 shares reported disposed at $0 (reflects the option conversion/exercise)
- Net change to beneficial ownership from these transactions: zero (7,930 acquired, 7,930 sold)
- Footnotes: F1 — sale effected under a Rule 10b5-1 trading plan adopted March 14, 2025; F2 — holdings include 679 RSUs previously granted; F3 — option vesting schedule described (partial vesting starting April 1, 2024)
Context This was an exercise of stock options followed by an immediate open-market sale (a cashless-style transaction). The sale was carried out under a pre-established 10b5-1 plan, which is a routine mechanism insiders use to sell shares according to predetermined rules and not necessarily an indication of a change in outlook. The filing shows no net increase in shares held by the director from these entries.
Insider Transaction Report
- Exercise/Conversion
Common stock
[F1][F2]2026-03-13$11.18/sh+7,930$88,657→ 113,386 total - Sale
Common stock
[F1][F2]2026-03-13$41.40/sh−7,930$328,302→ 105,456 total - Exercise/Conversion
Stock Option (right to buy)
[F1][F3]2026-03-13−7,930→ 63,440 totalExercise: $11.18Exp: 2028-04-12→ Common stock (7,930 underlying)
Footnotes (3)
- [F1]The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
- [F2]Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
- [F3]The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date